लोड हो रहा है...

Lobelane Inhibits Methamphetamine-Evoked Dopamine Release via Inhibition of the Vesicular Monoamine Transporter-2

Lobeline is currently being evaluated in clinical trials as a methamphetamine abuse treatment. Lobeline interacts with nicotinic receptor subtypes, dopamine transporters (DATs), and vesicular monoamine transporters (VMAT2s). Methamphetamine inhibits VMAT2 and promotes dopamine (DA) release from syna...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Nickell, Justin R., Krishnamurthy, Sairam, Norrholm, Seth, Deaciuc, Gabriela, Siripurapu, Kiran B., Zheng, Guangrong, Crooks, Peter A., Dwoskin, Linda P.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: The American Society for Pharmacology and Experimental Therapeutics 2010
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2812121/
https://ncbi.nlm.nih.gov/pubmed/19855096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.109.160275
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!